Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - orthopaedics - l&k biomed castleloc-p anterior cervical plate system is intended for anterior screw fixation to the cervical spine (c2-c7). the system is indicated for use in the immobilization and stabilization of the spine as an adjunct to fusions in patients with: • degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), • spondylolisthesis, • trauma (i.e. fractures or dislocations), • tumors, • deformity (defined as kyphosis, lordosis, or scoliosis), • failed previous fusion (pseudoarthrosis) • spinal stenosis.”

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - orthopaedics - lnk lumbar interbody fusion cage system is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one or two contiguous levels from l2-s1. ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. these ddd patients may also have up to grade 1 spondylolisthesis or retrolisthes is at the involved level(s).this device is to be used with autogenous bone graft. lnk lumbar interbody fusion cage system is to be used with supplemental fixation. patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - orthopaedics - l&k biomed pathloc-l mis spinal system is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine. and the pathloc-l mis spinal system can be used in an open approach and a percutaneous approach. the pathloc-l mis spinal system is intended for the following indications: - degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies) - spondylolisthesis - trauma(i.e., fracture or dislocation) - spinal stenosis - curvatures(i.e., scoliosis, kyphosis, and for lordosis) - tumor - pseudarthrosis - failed previous fusion’.

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - orthopaedics - the pathloc-lc lateral cage system is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disease (ddd) at one or two contiguous levels from l1-s1. ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. these ddd patients may also have up to grade 1 spondyloisthesis or retrolisthesis at the involved level(s). this device is to be used with autogenous bone graft. pathloc-lc lateral cage system is to be used with supplemental fixation. patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.’

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general hospital - the cellu m6® alliance medical device is intended for therapeutic use. it can be used to : 1. reduce secondary lymphedema of the arm after a mastectomy 2. improve secondary lymphedema 3. improve lymphatic circulation in the treated area 4. relief of minor muscle aches and pains 5. relieve muscle spasms 6. temporary improvement in local blood circulation 7. temporary relief of the minor muscular pain associated with doms (delayed onset muscle soreness) 8. improves local circulation during burn rehabilitation 9. reduce the appearance of cellulite and the circumference of treated areas 10. temporarily improve lymphatic circulation and local blood circulation to improve skin trophicity in the treated areas 11. improvement of skin quality, scars, fibrosis 12. improvement of skin aging (wrinkles, fine lines, skin sagging, fat infiltration, firmness, elasticity, complexion, eye bags) 13. stimulation of fibroblasts (collagen, elastin, hyaluronic acid synthesis)

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general hospital - for vascular access devices flushing only. may be placed on sterile field.

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general & plastic surgery - the obp medical onetrac single-use lighted retractor is indicated for use to retract soft tissue in order to enhance exposure during surgical procedures.

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general & plastic surgery - is an injectable implant indicated for the filling of superficial skin depressions, to reduce peri-orbital and peri-buccal fine lines as well as those on the forehead by injection into the superficial dermis.

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general & plastic surgery - is an injectable implant for subcutaneous injection. it is indicated for the filling of deep lines and depressions such as nasolabial folds and marionette lines. it is also indicated for moderate contouring and volumisation in areas such as cheekbones, chin, jawline, temples, nose, and for lip augmentation

Singapore - English - HSA (Health Sciences Authority)

emergo singapore consulting private limited - general & plastic surgery - is an injectable implant for subcutaneous injection indicated for the filling of medium lines and depressions, such as nasolabial folds and marionette lines, for lip enhancement and scars.